{"title":"Revisiting radiotherapy for pancreatic cancer","authors":"R. Tuli","doi":"10.21037/apc.2018.08.01","DOIUrl":null,"url":null,"abstract":"Pancreatic cancer is the eighth most common cancer diagnosed in the United States (US) yet the third deadliest. This devastating disease is estimated to become the second leading cause of cancer deaths by 2030 largely due to the high rate of occult metastatic disease and significant tumor heterogeneity, rendering unselected therapies ineffective.","PeriodicalId":8372,"journal":{"name":"Annals of Pancreatic Cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Pancreatic Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/apc.2018.08.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Pancreatic cancer is the eighth most common cancer diagnosed in the United States (US) yet the third deadliest. This devastating disease is estimated to become the second leading cause of cancer deaths by 2030 largely due to the high rate of occult metastatic disease and significant tumor heterogeneity, rendering unselected therapies ineffective.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
